295 related articles for article (PubMed ID: 28197963)
21. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review.
Shadman M
JAMA; 2023 Mar; 329(11):918-932. PubMed ID: 36943212
[TBL] [Abstract][Full Text] [Related]
22. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
23. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
24. Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H.
Rodon P; Breton P; Courouble G
Eur J Haematol; 2003 May; 70(5):319-21. PubMed ID: 12694169
[TBL] [Abstract][Full Text] [Related]
25. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
[TBL] [Abstract][Full Text] [Related]
27. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
[TBL] [Abstract][Full Text] [Related]
29. Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Vitale C; Salvetti C; Griggio V; Porrazzo M; Schiattone L; Zamprogna G; Visentin A; Vassallo F; Cassin R; Rigolin GM; Murru R; Laurenti L; Rivela P; Marchetti M; Pennese E; Gentile M; Boccellato E; Perutelli F; Montalbano MC; De Paoli L; Reda G; Orsucci L; Trentin L; Cuneo A; Tedeschi A; Scarfò L; Gaidano G; Mauro FR; Foà R; Boccadoro M; Coscia M
Blood; 2021 Jun; 137(25):3507-3517. PubMed ID: 33651883
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
31. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Michallet AS; Rossignol J; Cazin B; Ysebaert L
Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.
Ghazal H
Blood; 2002 Feb; 99(3):1092-4. PubMed ID: 11807020
[TBL] [Abstract][Full Text] [Related]
33. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.
Vitale C; Montalbano MC; Salvetti C; Boccellato E; Griggio V; Boccadoro M; Coscia M
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979293
[TBL] [Abstract][Full Text] [Related]
35. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
36. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
[TBL] [Abstract][Full Text] [Related]
37. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
Zaja F; Vianelli N; Sperotto A; Patriarca F; Tani M; Marin L; Tiribelli M; Candoni A; Baccarani M; Fanin R
Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
[TBL] [Abstract][Full Text] [Related]
38. Unusual complications in the management of chronic lymphocytic leukemia.
Gordon MJ; Ferrajoli A
Am J Hematol; 2022 Nov; 97 Suppl 2():S26-S34. PubMed ID: 35491515
[TBL] [Abstract][Full Text] [Related]
39. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
[TBL] [Abstract][Full Text] [Related]
40. Can Treatment with Venetoclax for Chronic Lymphocytic Leukemia (CLL) Result In Autoimmune Hemolytic Anemia?
Abdel-Samad N; Sughayar R
Am J Case Rep; 2021 Mar; 22():e928514. PubMed ID: 33750754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]